Item 7.01 Regulation FD Disclosure
On
As previously disclosed, pursuant to the terms of the Stock Purchase Agreement
by and between
Adtalem has previously disclosed DVU-related matters that have consumed a portion of the Indemnification Cap.
To Adtalem's knowledge, DVU has not been contacted by the
Adtalem does not have any specific information on how the
Forward-Looking Statements
Certain statements contained in this Form 8-K are forward-looking statements as
defined in the Private Securities Litigation Reform Act of 1995. Forward-looking
statements provide current expectations of future events based on certain
assumptions and include any statement that does not directly relate to any
historical or current fact, which includes statements regarding the Company's
future growth, the future impacts of the COVID-19 pandemic, the efficacy and
distribution of the vaccines, the BDR program, Adtalem's indemnification of DVU,
the expected synergies from the recent Walden acquisition, and the pending sale
of the financial services segment, including our anticipated net proceeds and
whether the pending sale will be completed in the anticipated timeframe, if at
all. Forward-looking statements can also be identified by words such as
"future," "believe," "expect," "anticipate," "estimate," "plan," "intend,"
"may," "will," "would," "could," "can," "continue," "preliminary," "range," and
similar terms. These forward-looking statements are subject to risk and
uncertainties that could cause actual results to differ materially from those
described in the statements. These risks and uncertainties include the risk
factors described in Item 1A. "Risk Factors" of our most recent Annual Report on
Form 10-K filed with the
--------------------------------------------------------------------------------
© Edgar Online, source